Evaluating the Application Potential of a Recombinant Ganoderma Protein as Bioactive Ingredients in Cosmetics
Molecules · 06.04.2023 · 28 (7) · 3272
DOI: 10.3390/molecules28073272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 06.04.2023. Verfasst von Zhi-Jian Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shangh…. Hauptthemen laut MEDLINE: Ganoderma, Reishi, Melanoma, Experimental. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Project Funding of the Key Laboratory of Fermentation Engineering (Ministry of Education).
Abstract (Originalsprache)
The aim of this study was to evaluate the application potential of a recombinant fungal immunomodulatory protein from Ganoderma lucidum (rFIP-glu). First, a recombinant plasmid pPIC9K::FIP-glu-His was transferred into Pichia pastoris for the production of protein. The protein was then to assess its free radical scavenging abilities and the effect on the viability of both human immortalized keratinocytes (HaCaT cells) and mouse B16-F10 melanoma cells (B16 cells) in vitro, followed by the effect on the melanin synthesis of B16 cells. The results of SDS-PAGE and western blot showed that rFIP-glu was successfully expressed. Furtherly, a bioactivity assay in vitro indicated that the scavenging rate of 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals reached 84.5% at 6.0 mg/mL (p ≤ 0.0001) of rFIP-glu, showing strong antioxidant activity. Subsequently, a safety evaluation demonstrated that rFIP-glu promoted the proliferation of HaCaT cells, with the cell viability reaching 124.3% at 48 μg/mL (p ≤ 0.01), regarding the cell viability of B16 cells after exposure to rFIP-glu (48 μg/mL) significantly inhibited, to 80.7% (p ≤ 0.01). Besides, rFIP-glu inhibited the melanin synthesis of B16 cells in a dose-dependent manner from 100–1000 μg/mL, and rFIP-glu at 500 μg/mL (p ≤ 0.01) exhibited the highest intracellular melanin amount reduction of 16.8%. Furthermore, a mechanism analysis showed that rFIP-glu inhibited tyrosinase (TYR) activity by up-regulating the expression of the microphthalmia-associated transcription factor (MITF) and down-regulating the gene expression of TYR and tyrosinase-related protein-1 (TYRP-1), thus inhibiting melanin synthesis. The data implied that rFIP-glu had significant antioxidant activity and whitening potency. It should be used as raw materials for cosmeceutical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Agriculture and Biology, Engineering Research Center of Therapeutic Antibody (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Xuan-Wei Zhou
Förderung
- Open Project Funding of the Key Laboratory of Fermentation Engineering (Ministry of Education)
Zitieren
APA
Guo, Z. J., Liu, Y., Yang, J. Y., Jin, M. Y., Mao, P. W., & Zhou, X. W. (2023). Evaluating the Application Potential of a Recombinant Ganoderma Protein as Bioactive Ingredients in Cosmetics. Molecules, 28(7), 3272. https://doi.org/10.3390/molecules28073272
Vancouver
Guo ZJ, Liu Y, Yang JY, Jin MY, Mao PW, Zhou XW. Evaluating the Application Potential of a Recombinant Ganoderma Protein as Bioactive Ingredients in Cosmetics. Molecules. 2023;28(7):3272. doi:10.3390/molecules28073272
BibTeX
@article{Guo2023,
author = {Guo, Zhi-Jian and Liu, Yan and Yang, Jia-Yi and Jin, Meng-Yuan and Mao, Pei-Wen and Zhou, Xuan-Wei},
title = {Evaluating the Application Potential of a Recombinant Ganoderma Protein as Bioactive Ingredients in Cosmetics},
journal = {Molecules},
year = {2023},
volume = {28},
number = {7},
pages = {3272},
doi = {10.3390/molecules28073272}
}
EUVIMED